SEARCH

SEARCH BY CITATION

References

  • 1
    Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women: II, phenotypic characteristics and other host-related factors. Am J Epidemiol 1988; 141: 93442.
  • 2
    Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM, Osterlind A, Walter SD, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer 1995; 62: 36776.
  • 3
    Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HKB, Spinelli JJ, Beagrie M. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch Dermatol 1990; 126: 7706.
  • 4
    Osterlind A, Tucker MA, Hou-Jensen K, Stone BJ, Engholm G, Jensen OM. The Danish case-control study of cutaneous malignant melanoma: I, importance of host factors. Int J Cancer 1988; 42: 2006.
  • 5
    Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997; 73: 198203.
  • 6
    Whiteman D, Green A. Melanoma and sunburn. Cancer Causes Control 1994; 5: 56472.
  • 7
    Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Bronstein BR, Mihm MC Jr, Speizer FE. Melanoma and the sun: the effect of swimsuits and a “healthy” tan on the risk of nonfamilial malignant melanoma in women. Am J Epidemiol 1991; 134: 46270.
  • 8
    White E, Kirkpatrick CS, Lee JAH. Case-control study of malignant melanoma in Washington State. Am J Epidemiol 1994; 139: 85768.
  • 9
    Elder DE, Goldman LI, Goldman SC, Greene MK, Clark WH Jr. Dysplastic nevus syndrome: a phenotypic association of sporadic melanoma. Cancer 1980; 46: 178794.
  • 10
    Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JAA, Clark J, Hole DJ. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986; 292: 15559.
  • 11
    Holly EA, Kelly JW, Shpall SN, Chiu S-H. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17: 45968.
  • 12
    Grulich AE, Bataille V, Swerdlow AJ, Newton-Bishop JA, Cuzick J, Hersey P, McCarthy WH. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer 1996; 67: 48591.
  • 13
    Augustsson A, Stierner U, Rosdahl I, Suurkula M. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Dermatol Venereol 1991; 71: 51824.
  • 14
    Garbe C, Buttner P, Weib J, Soyer HP, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol 1994; 102: 6959.
  • 15
    Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, Noe MC, Diconstanzo MP, Bonerandi JJ. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66: 38795.
  • 16
    Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, Guerry DIV, Clark WH Jr. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. J Am Med Assoc 1997; 277: 143944.
  • 17
    Youl P, Aitken J, Hayward N, Hogg D, Liu L, Lassam N, Martin N, Green A. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int J Cancer 2002; 98: 928.
  • 18
    Green A, MacLennan R, Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer 1985; 35: 297300.
  • 19
    Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M, Grossman L. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 2002; 94: 94101.
  • 20
    Halpern AC, Guerry DIV, Elder DE, Clark WH, Synnestvedt M, Norman S, Ayerle R. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. Arch Dermatol 1991; 127: 9959.
  • 21
    Nordlund JJ, Kirkwood J, Forget BM, Scheibner A, Albert DM, Lerner E, Milton GW. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985; 45: 185561.
  • 22
    Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73: 160511.
  • 23
    Titus-Ernstoff L, Duray PH, Ernstoff MS, Barnhill RL, Horn PL, Kirkwood JM. Dysplastic nevi in association with multiple primary melanoma. Cancer Res 1988; 48: 10168.
  • 24
    Breslow NE, Day NE. Statistical methods in cancer research: VII, the design and analysis of cohort studies. Lyon: IARC, 1987.
  • 25
    Duray PH, Ernstoff MS. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Arch Dermatol 1987; 123: 804.
  • 26
    Rhodes AR, Harrist TJ, Day CL. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 1983; 9: 56374.
  • 27
    Gruber SB, Barnhill RL, Stenn KS, Roush GC. Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol 1989; 21: 77380.
  • 28
    Titus-Ernstoff L, Ernstoff MS, Duray PH, Barnhill RL, Holubkov R, Kirkwood JM. A relationship between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma. Epidemiology 1991; 2: 2104.
  • 29
    Karlsson P, Stenberg B, Rosdahl I. Prevalence of pigmented naevi in a Swedish population close to the Arctic Circle. Acta Dermatol Venereol 2000; 80: 3359.
  • 30
    Augusstson A, Stierner U, Suurkula M, Rosdahl I. Prevalence of common and dysplastic naevi in a Swedish population. Br J Dermatol 1991; 142: 1526.
  • 31
    Titus-Ernstoff L, Mansson-Brahme EM, Thorn M, Yuen J, Baron JA, Ding J, Dain B, Adami H-O. Factors associated with atypical nevi: a population-based study. Cancer Epidemiol Biomarkers Prev 1998; 7: 20110.
  • 32
    Elder DE, Goldman LI, Goldman SC, Greene MH, Clark WH Jr. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer 1980; 46: 178794.